These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
932 related articles for article (PubMed ID: 12515823)
1. A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy. Monani UR; Pastore MT; Gavrilina TO; Jablonka S; Le TT; Andreassi C; DiCocco JM; Lorson C; Androphy EJ; Sendtner M; Podell M; Burghes AH J Cell Biol; 2003 Jan; 160(1):41-52. PubMed ID: 12515823 [TBL] [Abstract][Full Text] [Related]
2. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy. Monani UR; Sendtner M; Coovert DD; Parsons DW; Andreassi C; Le TT; Jablonka S; Schrank B; Rossoll W; Prior TW; Morris GE; Burghes AH Hum Mol Genet; 2000 Feb; 9(3):333-9. PubMed ID: 10655541 [TBL] [Abstract][Full Text] [Related]
3. Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect. Gavrilina TO; McGovern VL; Workman E; Crawford TO; Gogliotti RG; DiDonato CJ; Monani UR; Morris GE; Burghes AH Hum Mol Genet; 2008 Apr; 17(8):1063-75. PubMed ID: 18178576 [TBL] [Abstract][Full Text] [Related]
4. Molecular and functional analysis of intragenic SMN1 mutations in patients with spinal muscular atrophy. Sun Y; Grimmler M; Schwarzer V; Schoenen F; Fischer U; Wirth B Hum Mutat; 2005 Jan; 25(1):64-71. PubMed ID: 15580564 [TBL] [Abstract][Full Text] [Related]
5. Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells. Grzeschik SM; Ganta M; Prior TW; Heavlin WD; Wang CH Ann Neurol; 2005 Aug; 58(2):194-202. PubMed ID: 16049920 [TBL] [Abstract][Full Text] [Related]
6. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Wirth B Hum Mutat; 2000; 15(3):228-37. PubMed ID: 10679938 [TBL] [Abstract][Full Text] [Related]
7. A genetic and phenotypic analysis in Spanish spinal muscular atrophy patients with c.399_402del AGAG, the most frequently found subtle mutation in the SMN1 gene. Cuscó I; López E; Soler-Botija C; Jesús Barceló M; Baiget M; Tizzano EF Hum Mutat; 2003 Aug; 22(2):136-43. PubMed ID: 12872254 [TBL] [Abstract][Full Text] [Related]
8. Specific interaction of Smn, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp/hnRNP-Q: a role for Smn in RNA processing in motor axons? Rossoll W; Kröning AK; Ohndorf UM; Steegborn C; Jablonka S; Sendtner M Hum Mol Genet; 2002 Jan; 11(1):93-105. PubMed ID: 11773003 [TBL] [Abstract][Full Text] [Related]
9. SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Le TT; Pham LT; Butchbach ME; Zhang HL; Monani UR; Coovert DD; Gavrilina TO; Xing L; Bassell GJ; Burghes AH Hum Mol Genet; 2005 Mar; 14(6):845-57. PubMed ID: 15703193 [TBL] [Abstract][Full Text] [Related]
10. Survival motor neuron SMN1 and SMN2 gene promoters: identical sequences and differential expression in neurons and non-neuronal cells. Boda B; Mas C; Giudicelli C; Nepote V; Guimiot F; Levacher B; Zvara A; Santha M; LeGall I; Simonneau M Eur J Hum Genet; 2004 Sep; 12(9):729-37. PubMed ID: 15162126 [TBL] [Abstract][Full Text] [Related]
11. 5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells. Yuo CY; Lin HH; Chang YS; Yang WK; Chang JG Ann Neurol; 2008 Jan; 63(1):26-34. PubMed ID: 17924536 [TBL] [Abstract][Full Text] [Related]
12. SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS. Veldink JH; Kalmijn S; Van der Hout AH; Lemmink HH; Groeneveld GJ; Lummen C; Scheffer H; Wokke JH; Van den Berg LH Neurology; 2005 Sep; 65(6):820-5. PubMed ID: 16093455 [TBL] [Abstract][Full Text] [Related]
13. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy. Riessland M; Ackermann B; Förster A; Jakubik M; Hauke J; Garbes L; Fritzsche I; Mende Y; Blumcke I; Hahnen E; Wirth B Hum Mol Genet; 2010 Apr; 19(8):1492-506. PubMed ID: 20097677 [TBL] [Abstract][Full Text] [Related]
14. Therapeutics development for spinal muscular atrophy. Sumner CJ NeuroRx; 2006 Apr; 3(2):235-45. PubMed ID: 16554261 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy. Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293 [TBL] [Abstract][Full Text] [Related]
17. Genetic study of SMA patients without homozygous SMN1 deletions: identification of compound heterozygotes and characterisation of novel intragenic SMN1 mutations. Martín Y; Valero A; del Castillo E; Pascual SI; Hernández-Chico C Hum Genet; 2002 Mar; 110(3):257-63. PubMed ID: 11935338 [TBL] [Abstract][Full Text] [Related]
18. A mouse model for spinal muscular atrophy. Hsieh-Li HM; Chang JG; Jong YJ; Wu MH; Wang NM; Tsai CH; Li H Nat Genet; 2000 Jan; 24(1):66-70. PubMed ID: 10615130 [TBL] [Abstract][Full Text] [Related]
20. A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels. Wolstencroft EC; Mattis V; Bajer AA; Young PJ; Lorson CL Hum Mol Genet; 2005 May; 14(9):1199-210. PubMed ID: 15790598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]